Takeshi Yokoyama
Sugitani, 9300914, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Identification of Acoramidis as a Repurposed Inhibitor of the DNA Sanitization Enzyme MutT Homologue 1.
Journal: ACS pharmacology & translational science
Published: December 03, 2025
Repurposing of Agrochemicals as ATTRv Amyloidosis Inhibitors.
Journal: Journal of medicinal chemistry
Published: January 06, 2025
Divergent Total Synthesis of Isoflavone Natural Products and Their Potential as Therapeutic Agents for TTR Amyloidosis.
Journal: Journal of natural products
Published: October 27, 2024
Discovery and optimization of isoliquiritigenin as a death-associated protein kinase 1 inhibitor.
Journal: European journal of medicinal chemistry
Published: August 07, 2024
Development of Benziodarone Analogues with Enhanced Potency for Selective Binding to Transthyretin in Human Plasma.
Journal: Journal of medicinal chemistry
Published: April 26, 2024
Structural insights into rapamycin-induced oligomerization of a FRB-FKBP fusion protein.
Journal: FEBS letters
Published: March 07, 2024
Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin.
Journal: Journal of medicinal chemistry
Published: November 01, 2023
Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis.
Journal: Bioorganic & medicinal chemistry
Published: April 24, 2023
Rafoxanide, a salicylanilide anthelmintic, interacts with human plasma protein transthyretin.
Journal: The FEBS journal
Published: March 19, 2023
Last Updated: 09/26/2026